Thiotepa in conditioning before transplantation

DRUG2 trials

Sponsors

Lund University Hospital, Seoul National University Hospital

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaCentral Nervous System Lymphoma

Phase 2

Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia

CompletedNCT01025778

Lund University HospitalAcute Lymphoblastic Leukemia, Acute Myeloid Leukemia

Start: 2009-12-31End: 2012-12-31Updated: 2021-02-21

High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma

TerminatedNCT06625359

Seoul National University HospitalCentral Nervous System Lymphoma

Start: 2015-06-01End: 2024-09-30Updated: 2024-10-03

Related Papers

Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study.

2025-06-14

The combination of clofarabine, etoposide, and cyclophosphamide shows limited efficacy as a bridge to transplant for children with refractory acute leukemia: results of a monitored prospective study

Pediatric Hematology and Oncology2020-11-051 citations